Across TCGA pan-cancer cohorts, RNA5SP366 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNA5SP366’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNA5SP366 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP366 is over-expressed in tumor.

BRCA and COAD are the cancer types where RNA5SP366 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP366 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.092	.044	2	view →
COAD	All	II,III,IV	+0.182	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNA5SP366 RNA expression & survival · all RNA5SP366 data types